No clear link between fine air pollution and ovarian cancer, pooled data show

Endometrial and ovarian cancers are the most commonly diagnosed gynaecologic malignancies in the United States, and endometrial cancer incidence is rising in some population subgroups without a clear explanation. Chemicals in the wider environment are biologically plausible contributors, yet they have received far less scientific attention than lifestyle or genetic risk factors. Until now nobody had pulled the scattered evidence together to see what it actually shows. This review set out to map that literature and, where enough studies existed, to pool their results.

The team systematically searched for population studies linking environmental chemical exposures to the incidence or mortality of ovarian or endometrial cancer. In total 145 studies met their criteria: 78 looked at ovarian cancer only, 75 were conducted in North America and 58 followed groups of people over time. Outdoor air pollution was the most studied exposure, appearing in 27 studies, followed by ultraviolet light in 22 and pesticides in 16. For fine particulate matter, the single most investigated pollutant, they pooled results from seven studies.

For ovarian cancer, pooling four studies of PM2.5 showed no association, and the result held in the three studies that also accounted for other pollutants. For endometrial cancer, the pooled estimate from five studies was weakly elevated, and it stayed marginally raised when limited to studies that adjusted for co-pollutants or counted only new cases. Beyond PM2.5, the exposures studied varied so widely that no other pooled analysis was possible. The overriding conclusion was that the literature is sparse, particularly for endometrial cancer.

This is less a verdict than a map of a mostly empty landscape. It confirms that environmental risk factors for gynaecologic cancers are understudied, and it flags the limited work on endometrial cancer as a genuine gap given its unexplained rise. The weak endometrial signal for PM2.5 is intriguing but far from established, and the null for ovarian cancer rests on only a few studies. Open questions include which chemicals deserve priority and whether particular groups of women face different risks.

If you have worried that air pollution might be quietly driving ovarian cancer risk, the pooled evidence so far offers no support for that fear. The faint endometrial cancer signal is worth watching but far too weak and uncertain to act on. This is a field where the honest summary is that science has barely started asking the questions, so absence of evidence should not be read as proof of safety, nor as any reason for alarm.